Skip to main content
TipRanks
Go Ultimate75% OFF

PharmX Technologies (PHX) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

PharmX Technologies has a market cap or net worth of AUD 46.13M. The enterprise value is AUD 79.67M.

Market Cap
AUD 46.13M
Enterprise Value
AUD 79.67M

Share Statistics

PharmX Technologies has 668,618,650 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
668,618,650
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

PharmX Technologies’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -7.79%.

Return on Equity (ROE)
-0.08
Return on Assets (ROA)
-0.07
Return on Invested Capital (ROIC)
-7.79%
Return on Capital Employed (ROCE)
-0.09
Revenue Per Employee
846.33K
Profits Per Employee
-202.89K
Employee Count
9
Asset Turnover
0.28
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of PharmX Technologies is -16.56. PharmX Technologies’s PEG ratio is 0.16.

PE Ratio
-16.56
PS Ratio
3.80
PB Ratio
1.75
Price to FCF
39.47
Price to Operating Cash Flow
36.44
PEG Ratio
0.16

Income Statement

In the last 12 months, PharmX Technologies had revenue of 7.62M and earned -1.83M in profits. Earnings per share was -0.00.

Revenue
7.62M
Gross Profit
-70.00K
Operating Income
-2.09M
Pretax Income
-2.01M
Net Income
-1.83M
EBITDA
-532.00K
Earnings Per Share (EPS)
-0.00

Cash Flow

In the last 12 months, operating cash flow was 1.12M and capital expenditures -20,000, giving a free cash flow of 1.10M billion.

Operating Cash Flow
1.12M
Free Cash Flow
1.10M
Free Cash Flow per Share
0.00

Dividends & Yields

PharmX Technologies pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
2.39%
Earnings Yield
-4.21%

Stock Price Statistics

Beta
0.65
52-Week Price Change
-54.00%
50-Day Moving Average
0.08
200-Day Moving Average
0.10
Relative Strength Index (RSI)
43.73
Average Volume (3m)
578.89K

Important Dates

PharmX Technologies upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 26, 2026
Next Earnings Date
Feb 25, 2027
Ex-Dividend Date
―

Financial Position

PharmX Technologies as a current ratio of 2.33, with Debt / Equity ratio of 2.32%

Current Ratio
2.33
Quick Ratio
2.33
Debt to Market Cap
0.00
Net Debt to EBITDA
3.82
Interest Coverage Ratio
-47.50

Taxes

In the past 12 months, PharmX Technologies has paid -188.00K in taxes.

Income Tax
-188.00K
Effective Tax Rate
0.09

Enterprise Valuation

PharmX Technologies EV to EBITDA ratio is 178.56, with an EV/FCF ratio of 40.06.

EV to Sales
3.86
EV to EBITDA
178.56
EV to Free Cash Flow
40.06
EV to Operating Cash Flow
39.34

Balance Sheet

PharmX Technologies has AUD 2.57M in cash and marketable securities with AUD 540.00K in debt, giving a net cash position of AUD 2.03M billion.

Cash & Marketable Securities
AUD 2.57M
Total Debt
AUD 540.00K
Net Cash
AUD 2.03M
Net Cash Per Share
AUD 0.00
Tangible Book Value Per Share
AUD 0.02

Margins

Gross margin is 8.05%, with operating margin of -18.29%, and net profit margin of -15.98%.

Gross Margin
8.05%
Operating Margin
-18.29%
Pretax Margin
-17.63%
Net Profit Margin
-15.98%
EBITDA Margin
2.16%
EBIT Margin
-18.29%

Analyst Forecast

The average price target for PharmX Technologies is AUD 0.16, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
AUD 0.16
Price Target Upside
124.64% Upside
Analyst Consensus
Moderate Buy
Analyst Count
2
Revenue Growth Forecast
4.06%
EPS Growth Forecast
-625.00%

Scores

Smart Score
7
AI Score
45